New therapies have raised Medicare treatment costs for metastatic prostate cancer
Medicare costs for treatment of metastatic prostate cancer have risen sharply within the last 15 years – reflecting increased use…
Medicare costs for treatment of metastatic prostate cancer have risen sharply within the last 15 years – reflecting increased use…
Researchers from The University of Texas MD Anderson Cancer Center demonstrated that adding metastasis-directed radiation therapy to intermittent hormone therapy improved progression-free…
Scientists have identified two subtypes of metastatic prostate cancer that respond differently to treatment, information that could one day guide…
A novel combination of well-known drugs prolongs survival in patients with hormone/castration-sensitive prostate cancer, according to late breaking research presented at the ESMO Congress 2021. (1,2) The PEACE-1 and STAMPEDE…